Gregor Bein

Giessen, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Paediatric outcomes after maternal nipocalimab for haemolytic disease of the fetus and newborn: an open-label, single-arm study.

Paediatric outcomes after maternal nipocalimab for haemolytic disease of the fetus and newborn: an open-label, single-arm study.

Journal: Archives of disease in childhood. Fetal and neonatal edition

Published: June 04, 2026

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

Journal: NEJM evidence

Published: January 27, 2026

Anti-HPA-1a IgG3 subclass antibodies induce strong platelet phagocytosis.

Anti-HPA-1a IgG3 subclass antibodies induce strong platelet phagocytosis.

Journal: British journal of haematology

Published: August 15, 2025

Anti-HLA antibodies bound to monocytes altered antibody-mediated platelet phagocytosis and led to mild thrombocytopenia.

Anti-HLA antibodies bound to monocytes altered antibody-mediated platelet phagocytosis and led to mild thrombocytopenia.

Journal: Frontiers in immunology

Published: June 23, 2025

Diagnosis and Management of Fetal and Neonatal Alloimmune Thrombocytopenia: An Update 2025.

Diagnosis and Management of Fetal and Neonatal Alloimmune Thrombocytopenia: An Update 2025.

Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Published: May 30, 2025

Platelet autoantibodies have an impact on the platelet count in patients.

Platelet autoantibodies have an impact on the platelet count in patients.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 03, 2024

Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.

Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.

Journal: The New England journal of medicine

Published: August 08, 2024

In vitro analysis of anti-HPA-1a dependent platelet phagocytosis and its inhibition using a new whole blood phagocytosis assay (WHOPPA).

In vitro analysis of anti-HPA-1a dependent platelet phagocytosis and its inhibition using a new whole blood phagocytosis assay (WHOPPA).

Journal: Frontiers in immunology

Published: August 29, 2023

Pregnant Women at Low Risk of Having a Child with Fetal and Neonatal Alloimmune Thrombocytopenia Do Not Require Treatment with Intravenous Immunoglobulin.

Pregnant Women at Low Risk of Having a Child with Fetal and Neonatal Alloimmune Thrombocytopenia Do Not Require Treatment with Intravenous Immunoglobulin.

Journal: Journal of clinical medicine

Published: July 19, 2023

The CD177 c.1291A Allele Leads to a Loss of Membrane Expression and Mimics a CD177-Null Phenotype.

The CD177 c.1291A Allele Leads to a Loss of Membrane Expression and Mimics a CD177-Null Phenotype.

Journal: International journal of molecular sciences

Published: July 14, 2023

Significant neutropenia induced by metamizole dependent neutrophil antibodies.

Significant neutropenia induced by metamizole dependent neutrophil antibodies.

Journal: Blood transfusion = Trasfusione del sangue

Published: February 28, 2023

Fetal and neonatal alloimmune thrombocytopenia: No evidence of systemic inflammation as a modulator of disease severity. Could placental inflammation be key?

Fetal and neonatal alloimmune thrombocytopenia: No evidence of systemic inflammation as a modulator of disease severity. Could placental inflammation be key?

Journal: British journal of haematology

Published: February 15, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026